DanielJSkiestMDProfessor of Medicine, UMASS Medi
Infectious Disease • Springfield, MAHIV/AIDS Medicine, Healthcare Associated Infections, STD Medicine
Vice- Chair, Department of Medicine, Baystate Health, Professor of Medicine, University of Mass Sch of Medicine
Dr. Skiest is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
759 Chestnut St
Springfield, MA 01199
Summary
- Dr. Daniel Skiest is an infectious disease specialist in Springfield, MA and is affiliated with multiple hospitals in the area, including Baystate Franklin Medical Center, Baystate Medical Center, Baystate Medical Center, and Baystate Mary Lane Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 29 years. He specializes in hiv/aids medicine and transplant/immunocompromised states.
Clinical Expertise
- HIV/AIDS, Infectious retinitis, Infectious disease, Infective endocarditis, Skin infections
Education & Training
University of ConnecticutFellowship, Infectious Disease, 1992 - 1994
University of MarylandResidency, Internal Medicine, 1988 - 1991
Case Western Reserve University School of MedicineClass of 1988
Certifications & Licensure
MA State Medical License 1991 - 2026
TX State Medical License 1994 - 2005
CT State Medical License 1993 - 1995
MD State Medical License 1989 - 1991- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Fellow Infectious Diseases Society of America
- Fellow American College of Physicians
- Weinberg award for research Baystate Health, 2017
- Join now to see all
Clinical Trials
- Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
- BRAVO: Background Regimen of Raltegravir on Virologic Outcome Start of enrollment: 2008 Mar 01
- Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 129 citationsThe Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical StudiesGolnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta
The Journal of Infectious Diseases. 2018-11-05 - 161 citationsNeurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohortKevin Robertson, Zhaohui Su, David M. Margolis, Amy Krambrink, Diane V. Havlir
Neurology. 2010-04-20 - 614 citationsTocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.Ivan O. Rosas, Norbert Bräu, Michael F. Waters, Ronaldo C. Go, Bradley D Hunter
The New England Journal of Medicine. 2021-02-25
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
Press Mentions
Breakthrough Infections Remain Low Percentage of Total COVID-19 Cases in MassachusettsDecember 20th, 2021- Pfizer COVID-19 Booster Shot Reminder: Did You Get the Call?October 8th, 2021
- Cases Going down as Pfizer Seeks EUA for Its Vaccine for Children 5 to 11October 7th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
